Skip to main content
Advertisement
Advertisement

BVS

BVS logo

Bioventus Inc. Class A Common Stock

13.53
USD
Sponsored
+0.46
+3.56%
Oct 12, 15:59 UTC -4
Closed
exchange

After-Market

13.61

+0.08
+0.59%

BVS Earnings Reports

Positive Surprise Ratio

BVS beat 17 of 23 last estimates.

74%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$150.91M
/
$0.15
Implied change from Q2 26 (Revenue/ EPS)
-1.50%
/
-31.82%
Implied change from Q3 25 (Revenue/ EPS)
+8.84%
/
--

Bioventus Inc. Class A Common Stock earnings per share and revenue

On Aug 05, 2026, BVS reported earnings of 0.22 USD per share (EPS) for Q2 26, beating the estimate of 0.21 USD, resulting in a 0.82% surprise. Revenue reached 153.21 million, compared to an expected 157.20 million, with a -2.54% difference. The market reacted with a +13.71% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.15 USD, with revenue projected to reach 150.91 million USD, implying an decrease of -31.82% EPS, and decrease of -1.50% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NanoViricides Inc.
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
For Q2 2026, Bioventus Inc. Class A Common Stock reported EPS of $0.22, beating estimates by 0.82%, and revenue of $153.21M, -2.54% below expectations.
The stock price moved up 13.71%, changed from $13.42 before the earnings release to $15.26 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 4 analysts, Bioventus Inc. Class A Common Stock is expected to report EPS of $0.15 and revenue of $150.91M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement